| Expert consensus document: defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment L Fabritz, E Guasch, C Antoniades, I Bardinet, G Benninger, TR Betts, ... Nature reviews. Cardiology 13 (4), 230, 2016 | 146 | 2016 |
| Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference D Kotecha, G Breithardt, AJ Camm, GYH Lip, U Schotten, A Ahlsson, ... Ep Europace 20 (3), 395-407, 2018 | 143 | 2018 |
| Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation W Chua, Y Purmah, VR Cardoso, GV Gkoutos, SP Tull, G Neculau, ... European heart journal 40 (16), 1268-1276, 2019 | 127 | 2019 |
| European Society of Cardiology smartphone and tablet applications for patients with atrial fibrillation and their health care providers D Kotecha, WWL Chua, L Fabritz, J Hendriks, B Casadei, U Schotten, ... EP Europace 20 (2), 225-233, 2018 | 102 | 2018 |
| Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models J Dretzke, N Chuchu, R Agarwal, C Herd, W Chua, L Fabritz, S Bayliss, ... EP Europace 22 (5), 748-760, 2020 | 92 | 2020 |
| Mobile apps to improve medication adherence in cardiovascular disease: systematic review and meta-analysis S Al-Arkee, J Mason, DA Lane, L Fabritz, W Chua, MS Haque, Z Jalal Journal of medical Internet research 23 (5), e24190, 2021 | 88 | 2021 |
| Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference RB Schnabel, EA Marinelli, E Arbelo, G Boriani, S Boveda, CM Buckley, ... Europace 25 (1), 6-27, 2023 | 82 | 2023 |
| Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation JS Reyat, W Chua, VR Cardoso, A Witten, PM Kastner, SN Kabir, ... JCI insight 5 (16), 2020 | 53 | 2020 |
| Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference L Fabritz, HJGM Crijns, E Guasch, A Goette, KG Häusler, D Kotecha, ... EP Europace 23 (3), 329-344, 2021 | 51 | 2021 |
| Strabismus-related prejudice in 5–6-year-old children H Lukman, JE Kiat, A Ganesan, WL Chua, KL Khor, YF Choong British journal of ophthalmology 94 (10), 1348-1351, 2010 | 38 | 2010 |
| Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5 M Kloosterman, W Chua, L Fabritz, HR Al-Khalidi, U Schotten, JC Nielsen, ... EP Europace 22 (7), 1026-1035, 2020 | 32 | 2020 |
| Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy JP Law, AM Price, L Pickup, A Radhakrishnan, C Weston, AM Jones, ... Journal of the American Heart Association 9 (7), e016041, 2020 | 32 | 2020 |
| Atrial Fibrillation Guidelines Taskforce, the CATCH ME consortium and the European Heart Rhythm Association (EHRA). European Society of Cardiology smartphone and tablet … D Kotecha, WWL Chua, L Fabritz, J Hendriks, B Casadei, U Schotten, ... Europace 20 (2), 225-233, 2018 | 32 | 2018 |
| Predictors of recurrence of atrial fibrillation within the first 3 months after ablation MD Zink, W Chua, S Zeemering, L Di Biase, BL Antoni, C David, ... EP Europace 22 (9), 1337-1344, 2020 | 28 | 2020 |
| Negative social reaction to strabismus in school children ages 8-12 years H Lukman, JE Kiat, A Ganesan, WL Chua, KL Khor, YF Choong Journal of American Association for Pediatric Ophthalmology and Strabismus …, 2011 | 27 | 2011 |
| The biomarkers NT-proBNP and CA-125 are elevated in patients with idiopathic atrial fibrillation EAMP Dudink, B Weijs, S Tull, JGLM Luermans, L Fabritz, W Chua, ... Journal of atrial fibrillation 11 (4), 2018 | 25 | 2018 |
| Modelling single-person and multi-person event-based synchronisation MT Elliott, WL Chua, AM Wing Current Opinion in Behavioral Sciences 8, 167-174, 2016 | 24 | 2016 |
| Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment L Fabritz, E Guasch, C Antoniades, I Bardinet, G Benninger, TR Betts, ... Nature Reviews Cardiology 13 (4), 230-237, 2016 | 21 | 2016 |
| Interactions between atrial fibrillation and natriuretic peptide in predicting heart failure hospitalization or cardiovascular death PF Brady, W Chua, F Nehaj, DL Connolly, A Khashaba, YJV Purmah, ... Journal of the American Heart Association 11 (4), e022833, 2022 | 18 | 2022 |
| Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A … W Chua, JP Law, VR Cardoso, Y Purmah, G Neculau, M Jawad-Ul-Qamar, ... PLoS medicine 18 (2), e1003405, 2021 | 16 | 2021 |
